*Data is delayed | Exchange | USD
Last | 09/25/24 EDT
0.046UNCH (UNCH)
52 week range
0.03
-
0.28
- Open0.00
- Day High0.00
- Day Low0.00
- Prev Close0.046
- 52 Week High0.28
- 52 Week High Date12/05/23
- 52 Week Low0.03
- 52 Week Low Date09/12/24
Key Stats
- Market Cap7.921M
- Shares Out172.20M
- 10 Day Average Volume99,765.63
- Dividend-
- Dividend Yield-
- Beta-3.27
- YTD % Change-73.4
KEY STATS
- Open0.00
- Day High0.00
- Day Low0.00
- Prev Close0.046
- 52 Week High0.28
- 52 Week High Date12/05/23
- 52 Week Low0.03
- 52 Week Low Date09/12/24
- Market Cap7.921M
- Shares Out172.20M
- 10 Day Average Volume99,765.63
- Dividend-
- Dividend Yield-
- Beta-3.27
- YTD % Change-73.4
RATIOS/PROFITABILITY
- EPS (TTM)-0.01
- P/E (TTM)-4.67
- Fwd P/E (NTM)-
- EBITDA (TTM)-2.094M
- ROE (TTM)-2,362.09%
- Revenue (TTM)-
- Gross Margin (TTM)-
- Net Margin (TTM)-125.49%
- Debt To Equity (MRQ)-11.47%
EVENTS
- Earnings Date-
- Ex Div Date-
- Div Amount-
- Split Date-
- Split Factor-
Latest On Nascent Biotech Inc
Content From Our Affiliates
There is no recent news for this security.
Profile
Nascent Biotech, Inc. is a phase II clinical-stage biopharmaceutical company, which is engaged in developing monoclonal antibodies for the treatment of various cancer types. The Company focuses on biologic drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seeks to further develop those drug candidates for commercial use. It owns a drug candidate, Pritumumab, which the Company is developing as a...
Sean Carrick
President, Secretary, Director
Lowell Holden
Chief Financial Officer, Chief Accounting Officer, Director
Address
631 Us Hwy 1, Suite 407
North Palm Beach, FL
33408
United States